3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
7
Ovarian Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Mouth Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Mycosis Fungoides
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Colonic Neoplasms
2
Carcinoma
2
Brenner Tumor
2
Adenocarcinoma of Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Interventions
Rituximab
18
Cyclophosphamide
17
Prednisone
12
Doxorubicin
12
Vincristine
9
Lenalidomide
7
ibrutinib
6
obinutuzumab
5
glofitamab
5
Magnetic Resonance Spectroscopy
5
polatuzumab vedotin
4
fludarabine
4
Prednisolone
4
Oxaliplatin
4
Gemcitabine
4
Etoposide
4
venetoclax
3
pembrolizumab
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Specimen Handling
3
R-CHOP protocol
3
Cyclosporine
3
Biopsy
3
zanubrutinib
2
prednylidene
2
deltacortene
2
acalabrutinib
2
Mycophenolic Acid
2
Ifosfamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Immunoglobulin G
×
30 days
×
Clear all
No trials found.